Moyamoya disease: Difference between revisions

Jump to navigation Jump to search
Line 7: Line 7:
{{Moyamoya disease}}
{{Moyamoya disease}}
{{CMG}}
{{CMG}}
==Pathophysiology==
The condition is believed to be hereditary and linked to q25.3, on chromosome 17 [http://emedicine.medscape.com/article/1180952-overview#ClinicalCauses]. In Japan the overall incidence is higher (0.35 per 100,000).<ref name="pmid9409395">{{cite journal |author=Wakai K, Tamakoshi A, Ikezaki K, ''et al.'' |title=Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey |journal=[[Clin Neurol Neurosurg]] |volume=99 Suppl 2 |issue= |pages=S1–5 |year=1997 |pmid=9409395 |doi=10.1016/S0303-8467(97)00031-0}}</ref>  In North America, women in the third or fourth decade of life are most affected.  These women frequently experience transient ischemic attacks (TIA), cerebral hemorrhage or no symptoms.  They have a higher risk of recurrent stroke and may be experiencing a distinct underlying pathophysiology compared to patients from Japan.  Data suggest a potential benefit with surgery if early diagnosis is made.<ref name="pmid16645133">{{cite journal |author=Hallemeier C, Rich K, Brubb R, Chicoine M, Moran C, Cross D, Zipfel G, Dacey R, Derdeyn |title=Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey |journal=[[Stroke]] |volume=37 |issue= 6|pages=1490–1496 |year=2006 |pmid=16645133 |doi=10.1161/01.STR.0000221787.70503.ca}}</ref>  The pathogenesis of moyamoya disease is unknown.
Once it begins, the process of blockage (vascular occlusion) tends to continue despite any known medical management.  In some people this leads to repeated strokes and severe functional impairment or even death.  In others, this blockage may not cause any symptoms.
Moyamoya can be either congenital or acquired.  Patients with [[Down syndrome]], [[neurofibromatosis]], or [[sickle cell disease]] can develop moyamoya malformations.  It is more common in women than in men, although about a third of those affected are male .<ref name="pmid18048855">{{cite journal |author=Kuriyama S, Kusaka Y, Fujimura M, ''et al.'' |title=Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey |journal=Stroke |volume=39 |issue=1 |pages=42–7 |year=2008 |pmid=18048855 |doi=10.1161/STROKEAHA.107.490714 |url=http://stroke.ahajournals.org/cgi/pmidlookup?view=long&pmid=18048855}}</ref>  Brain radiation therapy in children with neurofibromatosis increases the risk of its development.


==Diagnosis==
==Diagnosis==

Revision as of 18:56, 26 February 2013

For patient information, click here

Moyamoya disease
Schematic representation of the circle of Willis, arteries of the brain and brain stem.

Moyamoya disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Moyamoya Disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Moyamoya disease On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Moyamoya disease

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Moyamoya disease

CDC on Moyamoya disease

Moyamoya disease in the news

Blogs on Moyamoya disease

Directions to Hospitals Treating Moyamoya disease

Risk calculators and risk factors for Moyamoya disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Diagnosis

The diagnosis is initially suggested by CT, MRI, or angiogram. In fact, the name derives from its angiographic image; the "puff of smoke," which is how moyamoya loosely translates from Japanese, refers to the appearance of multiple compensatorily dilated striate vessels seen on angiography. Contrast-enhanced T1-weighted images are better than FLAIR images for depicting the leptomeningeal ivy sign in moyamoya disease. MRI and MRA should be performed for the diagnosis and follow-up of moyamoya disease. Diffusion-weighted imaging can also be used for following the clinical course of children with moyamoya disease, in whom new focal deficits are highly suspicious of new infarcts.

Often nuclear medicine studies such as SPECT (single photon emission computerized tomography) are used to demonstrate the decreased blood and oxygen supply to areas of the brain involved with moyamoya disease. Conventional angiography provided the conclusive diagnosis of moyamoya disease in most cases and should be performed before any surgical considerations.

Treatment

There are many operations that have been developed for the condition, but currently the most favored are the in-direct procedures EDAS, EMS, and multiple burr holes and the direct procedure STA-MCA. Direct superficial temporal artery (STA) to middle cerebral artery (MCA) bypass is considered the treatment of choice, although its efficacy, particularly for hemorrhagic disease, remains uncertain. Multiple burr holes have been used in frontal and parietal lobes with good neovascularisation achieved.

The EDAS (encephaloduroarteriosynangiosis) procedure is a synangiosis procedure that requires dissection of a scalp artery over a course of several inches and then making a small temporary opening in the skull directly beneath the artery. The artery is then sutured to the surface of the brain and the bone replaced.

In the EMS (encephalomyosynangiosis) procedure, the temporalis muscle, which is in the temple region of the forehead, is dissected and through an opening in the skull placed onto the surface of the brain.

In the multiple burr holes procedure, multiple small holes (burr holes) are placed in the skull to allow for growth of new vessels into the brain from the scalp.

In the STA-MCA procedure, the scalp artery (superficial temporal artery or STA) is directly sutured to an artery on the surface of the brain (middle cerebral artery or MCA). This procedure is also commonly referred to as an EC-IC (External Carotid-Internal Carotid) bypass.

All of these operations have in common the concept of a blood and oxygen "starved" brain reaching out to grasp and develop new and more efficient means of bringing blood to the brain and bypassing the areas of blockage. The modified direct anastomosis and encephalo-myo-arterio-synagiosis play a role in this improvement by increasing cerebral blood flow (CBF) after the operation. A significant correlation is found between the postoperative effect and the stages of preoperative angiograms. It is crucial for surgery that the anesthesiologist have experience in managing children being treated for moyamoya as the type of anesthesia they require is very different from the standard anesthetic children get for almost any other type of neurosurgical procedure.

Prognosis

The natural history of this disorder is not well known. Symptomatic Moyamoya disease have occurred in individuals with seemingly asymptomatic stability thought due to vascular insufficiency secondary to brain trauma which may result from axonal shearing and acceleration / deceleration injuries such as falls and/or high speed motor vehicular accidents. The long term outlook for patients with treated moyamoya seems to be good.Template:Definition While symptoms may seem to improve almost immediately after the in-direct EDAS, EMS, and multiple burr holes surgeries, it will take probably 6–12 months before new vessels (blood supply) can develop sufficiently.[citation needed] With the direct STA-MCA surgery, increased blood supply is immediate.[citation needed]

Once major strokes or bleeding take place, even with treatment, the patient may be left with permanent loss of function so it is very important to treat this condition promptly.

References

External links

Template:Cerebrovascular diseases

de:Moyamoya id:Sindrom Moyamoya nl:Moyamoya-syndroom


Template:WikiDoc Sources